loadpatents
name:-0.024838924407959
name:-0.035742998123169
name:-0.0026779174804688
Peyman; Anuschirwan Patent Filings

Peyman; Anuschirwan

Patent Applications and Registrations

Patent applications and USPTO patent grants for Peyman; Anuschirwan.The latest application filed is for "oxybenzamide derivatives useful for inhibiting factor xa or vlla".

Company Profile
0.29.15
  • Peyman; Anuschirwan - Kelkheim DE
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Guanidine and amidine derivatives as factor Xa inhibitors
Grant 7,435,747 - Peyman , et al. October 14, 2
2008-10-14
Guanidino derivatives as inhibitors of cell adhesion
Grant 7,259,159 - Peyman , et al. August 21, 2
2007-08-21
G cap-stabilized oligonucleotides
Grant 7,229,974 - Peyman , et al. June 12, 2
2007-06-12
Oxybenzamide derivatives useful for inhibiting factor Xa or Vlla
Grant 7,067,665 - Nazare , et al. June 27, 2
2006-06-27
Process for the preparation of birthonectin receptor antagonists
Grant 6,992,187 - Peyman , et al. January 31, 2
2006-01-31
Oxybenzamide derivatives useful for inhibiting factor Xa or viia
Grant 6,953,857 - Nazare , et al. October 11, 2
2005-10-11
Oxybenzamide derivatives useful for inhibiting factor Xa or Vlla
App 20050165058 - Nazare, Marc ;   et al.
2005-07-28
Antisense oligonucleotides against tenascin for the treating of vitiligo
App 20050148017 - Peyman, Anuschirwan ;   et al.
2005-07-07
Guanidine and amidine derivatives as factor Xa inhibitors
App 20050143419 - Peyman, Anuschirwan ;   et al.
2005-06-30
Antisense oligonucleotides against tenascin for treating vitiligo
Grant 6,878,547 - Peyman , et al. April 12, 2
2005-04-12
(2S)-2-(adamantan-1-ylmethoxycarbonylamino)-3-(4-(2-(1,4,5,6-tetrhydropyrim idin-2-ylcarbamoyl)ethyl)benzoylamino)propionic acid isopropyl ester, its preparation and its use
Grant 6,867,213 - Peyman , et al. March 15, 2
2005-03-15
Vitronectin receptor antagonists, their preparation and their use
Grant 6,867,208 - Wehner , et al. March 15, 2
2005-03-15
Modified antisense nucleotides complementary to a section of the human haras gene
App 20050020523 - Uhlmann, Eugen ;   et al.
2005-01-27
Thienylalanine derivatives as inhibitors of cell adhesion
Grant 6,762,190 - Gadek , et al. July 13, 2
2004-07-13
Sulfonamide derivatives as inhibitors of bone resorption and as inhibitors of cell adhesion
Grant 6,747,148 - Peyman , et al. June 8, 2
2004-06-08
Substituted purine derivatives as inhibitors of cell adhesion
Grant 6,747,016 - Peyman , et al. June 8, 2
2004-06-08
Modified antisense nucleotides complementary to a section of the human Ha-ras gene
Grant 6,723,706 - Uhlmann , et al. April 20, 2
2004-04-20
Substituted purine derivatives, processes for their preparation, their use, and compositions comprising them
Grant 6,723,727 - Peyman , et al. April 20, 2
2004-04-20
Antisense oligonucleotides for the inhibition of integrin alphav -subunit expression
App 20030176384 - Uhlmann, Eugen ;   et al.
2003-09-18
Vitronectin receptor antagonists, their preparation and use
App 20030119785 - Wehner, Volkmar ;   et al.
2003-06-26
Thienylalanine derivatives as inhibitors of cell adhesion
App 20030105080 - Gadek, Thomas ;   et al.
2003-06-05
Modified Antisense Nucleotides Complementary To A Section Of The Human Ha-ras Gene
App 20030064514 - UHLMANN, EUGEN ;   et al.
2003-04-03
Vitronectin receptor antagonists, their preparation and their use
App 20030027807 - Wehner, Volkmar ;   et al.
2003-02-06
New oxybenzamide derivatives useful for inhibiting factor Xa or VIIa
App 20020198195 - Nazare, Marc ;   et al.
2002-12-26
Guanidine and amidine derivatives as factor Xa inhibitors
App 20020173656 - Peyman, Anuschirwan ;   et al.
2002-11-21
Vitronectin receptor antagonists, their preparation and their use
Grant 6,482,821 - Wehner , et al. November 19, 2
2002-11-19
G cap-stabilized oligonucleotides
App 20020151512 - Peyman, Anuschirwan ;   et al.
2002-10-17
Novel sulfonamide derivatives as inhibitors of bone resorption and as inhibitors of cell adhesion
App 20020065271 - Peyman, Anuschirwan ;   et al.
2002-05-30
Vitronectin receptor antagonists, their preparation and their use
Grant 6,387,895 - Wehner , et al. May 14, 2
2002-05-14
Stabilized oligonucleotides and their use
Grant 6,348,312 - Peyman , et al. February 19, 2
2002-02-19
3 modified oligonucleotide derivatives
Grant 6,326,487 - Peyman , et al. December 4, 2
2001-12-04
Short Oligonucleotides For The Inhibition Of Vegf Expression
App 20010021772 - UHLMANN, EUGEN ;   et al.
2001-09-13
Vitronectin receptor antagonists, their preparation and their use
App 20010011087 - Wehner, Volkmar ;   et al.
2001-08-02
Phosphonomonoester nucleic acids process for their preparation and their use
Grant 6,127,346 - Peyman , et al. October 3, 2
2000-10-03
G cap-stabilized oligonucleotides
Grant 6,121,434 - Peyman , et al. September 19, 2
2000-09-19
Oligonucleotide analogs, their preparation and use
Grant 6,033,909 - Uhlmann , et al. March 7, 2
2000-03-07
G cap-stabilized oligonucleotides
Grant 6,013,639 - Peyman , et al. January 11, 2
2000-01-11
Vitronectin receptor antagonists, their preparation and their use
Grant 6,011,045 - Wehner , et al. January 4, 2
2000-01-04
Vitronectin receptor antagonists, their preparation and their use
Grant 5,990,145 - Wehner , et al. November 23, 1
1999-11-23
Phosphonomonoester nucleic acids, process for their preparation, and their use
Grant 5,874,553 - Peyman , et al. February 23, 1
1999-02-23
Phosphinic acid derivatives, their preparation and their use
Grant 5,707,979 - Peyman , et al. January 13, 1
1998-01-13
3'-modified oligonucleotide derivatives
Grant 5,696,248 - Peyman , et al. December 9, 1
1997-12-09
3'-derivatized oligonucleotide analogs with non-nucleotidic groupings, their preparation and use
Grant 5,646,261 - Uhlmann , et al. July 8, 1
1997-07-08
Antisense oligonucleotides against HSV 1, and their preparation
Grant 5,563,050 - Peyman , et al. October 8, 1
1996-10-08

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed